bpc 157 systematic review 2025 BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Here's a nice graphic on
Description
The list below identifies populations where the risk-benefit picture is especially unclear and where independent research planning should err on the side of avoidance
Regulatory Peptides
By week 3 at the new dose, most researchers report minimal or no nausea
And when there are symptomsthings like fatigue, tingling hands, and feet, dizziness, and memory losstheyre often so non-specific that doctors wont always flag B12 deficiency as an obvious cause
(PubMed) Lee DH, Lim JS, Song K, Boo Y, Jacobs DR, Jr
No official human dosing standard exists, so doses should be set with a physician
